share_log
Reuters ·  May 9 07:16
Xeris Biopharma Holdings Inc - Tightening Full-Year 2024 Total Revenue Guidance to $175M-$200M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment